Tandem Diabetes Care
TNDM
321 hedge funds and large institutions have $6.16B invested in Tandem Diabetes Care in 2020 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 111 increasing their positions, 115 reducing their positions, and 36 closing their positions.
88% more call options, than puts
Call options by funds: $175M | Put options by funds: $92.9M
50% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 36
13% more capital invested
Capital invested by funds: $5.47B → $6.16B (+$690M)
6% more funds holding
Funds holding: 303 → 321 (+18)
3% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 115
2.44% less ownership
Funds ownership: 92.12% → 89.68% (-2.4%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$77.4M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$60.1M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$51.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.9M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$274M |
| 2 |
Millennium Management
New York
|
-$45.1M |
| 3 |
Renaissance Technologies
New York
|
-$41.2M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$27M |
| 5 |
Morgan Stanley
New York
|
-$22.3M |
TNDM Hedge Fund Activity: Q3 2020 in Review
321 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2020, worth a combined $6.16B — up 13% from $5.47B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new TNDM positions and 36 closed out — a net gain of 18 holders — while 111 added to existing stakes and 115 trimmed.
The largest buyer was Capital World Investors, adding an estimated $77.4M. The largest seller was Wellington Management Group, cutting an estimated $274M.
- 321 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2020, up from 303 in Q2 2020.
- Funds reported $6.16B of Tandem Diabetes Care stock for Q3 2020, up 13% quarter-over-quarter.
- 54 funds opened new Tandem Diabetes Care positions in Q3 2020 and 36 closed out, a net change of +18 holders.
- The largest Tandem Diabetes Care buyer in Q3 2020 was Capital World Investors, an estimated $77.4M added.
- The largest Tandem Diabetes Care seller in Q3 2020 was Wellington Management Group, an estimated $274M sold.
Based on aggregated 13F filings for Q3 2020.